Paid Clinical Trials in Canada

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Canada

Top of Directory » All Locations » Canada




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

    Conditions:   Breast Cancer;   Heart Failure
    Intervention:   Drug: perindopril (or placebo) OR bisoprolol (or placebo) OR both perindopril and bisoprolol OR placebo
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009

  • Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

    Conditions:   Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
    Intervention:   Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Recruiting - verified November 2009

  • STOP Study: Effectiveness of Zyban in a Clinical Population

    Conditions:   Cigarette Smoking;   Nicotine Addiction;   Smoking Cessation
    Interventions:   Drug: bupropion HCl;   Behavioral: smoking cessation counselling
    Sponsors:   Centre for Addiction and Mental Health;   Ontario Ministry of Health Promotion
    Recruiting - verified November 2009

  • Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

    Condition:   Peptic Ulcer Disease
    Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009

  • Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis

    Condition:   Ulcerative Proctitis
    Interventions:   Procedure: Proctosigmoidoscopy or colonoscopy with biopsy;   Procedure: Proctosigmoidoscopy;   Procedure: Blood collection;   Procedure: Electrocardiogram (ECG);   Drug: MAX-002;   Drug: Canasa®;   Drug: Placebo
    Sponsor:   Axcan Pharma
    Recruiting - verified November 2009

  • Spontaneous Atrioventricular Conduction Preservation

    Condition:   Patients With Pacemaker With Conduction Problems
    Intervention:   Device: Pacing mode
    Sponsors:   Montreal Heart Institute;   Sorin Group Canada
    Active, not recruiting - verified November 2009

  • An International Randomized Trial of Trans-radial Versus Trans-femoral PCI Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy

    Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
    Intervention:   Procedure: Percutaneous Coronary Intervention
    Sponsors:   Population Health Research Institute;   Co-sponsor: Sanofi-Aventis
    Recruiting - verified November 2009

  • Study on Duration of Bone Turnover Suppression Following Zoledronic Acid in Prostate Cancer

    Condition:   Prostate Cancer
    Intervention:  
    Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada
    Not yet recruiting - verified November 2009

  • A Safety/Proof of Concept Study to Evaluate the Effects of Oral QLT091001 in Children With Leber Congenital Amaurosis (LCA)

    Condition:   Visual Impairment Due to Leber Congenital Amaurosis (LCA)
    Intervention:   Drug: QLT091001
    Sponsor:   QLT Inc
    Recruiting - verified November 2009

  • Effect of Gastric Bypass on the Absorption of Metformin

    Conditions:   Obesity;   Gastric Bypass
    Intervention:  
    Sponsor:   University of Alberta
    Recruiting - verified November 2009

  • A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

    Conditions:   Renal Cell Carcinoma;   Cardiotoxicity;   Heart Failure;   Hypertension
    Intervention:  
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009

  • Self Titration With Apidra to Reach Target Study (START)

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine;   Drug: Apidra (insulin glulisine)
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009

  • Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Minimally Invasive, Diagnosis and Staging of Lung Cancer: A Prospective Head-to-Head Comparison With Traditional Gold Standard Techniques

    Condition:   Lung Cancer
    Interventions:   Procedure: Cervical Mediastinoscopy;   Procedure: Endobronchial Ultrasound (EBUS);   Procedure: Endoscopic Ultrasound (EUS)
    Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Fonds de la Recherche en Santé du Québec;   Society of University Surgeons;   Centre de Recherche du CHUM (CRCHUM);   Division de Chirurgie Thoracique du CHUM
    Recruiting - verified November 2009

  • In-vivo Wettability Grading and Assessment Study

    Condition:   Myopia
    Interventions:   Device: lotrafilcon B;   Device: Balafilcon A;   Device: Senofilcon A;   Device: enfilcon A
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Nadolol for Proliferating Infantile Hemangiomas

    Condition:   Infantile Hemangioma
    Intervention:   Drug: Nadolol
    Sponsor:   The Hospital for Sick Children
    Not yet recruiting - verified November 2009

  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH)

    Condition:   Healthy
    Interventions:   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: Placebo;   Drug: Human Growth Hormone
    Sponsor:   Ascendis Pharma A/S
    Active, not recruiting - verified November 2009

  • A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

    Condition:   Melanoma
    Interventions:   Drug: YM155;   Drug: Docetaxel
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Augment™ Injectable Bone Graft Compared to Autologous Bone Graft in Foot and Ankle Fusions

    Condition:   Ankle/Hindfoot Fusion
    Interventions:   Device: Augment™ Injectable;   Procedure: Standard of care
    Sponsor:   BioMimetic Therapeutics
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

    Conditions:   Crohn's Disease;   Inflammatory Bowel Disease
    Intervention:   Drug: AIN457
    Sponsor:   Novartis Pharmaceuticals
    Enrolling by invitation - verified November 2009

  • Treatment of the Metabolic Syndrome in an Interdisciplinary Obesity Clinic: a Randomized Controlled Study

    Conditions:   Obesity;   Metabolic Syndrome
    Intervention:   Behavioral: interdisciplinary intervention
    Sponsor:   Universitaire de Sherbrooke
    Completed - verified November 2009

  • The Potential Interference of Magnets From a Surgical Magnetic Drape With Cardiac Pacemakers

    Condition:   Cardiac Pacemaker, Artificial
    Intervention:  
    Sponsor:   Maisonneuve-Rosemont Hospital
    Recruiting - verified November 2009

  • Autologous Cell Therapy for Female Stress Urinary Incontinence

    Condition:   Stress Urinary Incontinence Cell Therapy
    Intervention:   Biological: Autologous Muscle Derived Cells
    Sponsor:   Cook
    Not yet recruiting - verified November 2009

  • Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU

    Condition:   Influenza A Virus H1N1 Subtype
    Intervention:   Drug: Oseltamivir
    Sponsors:   University of Manitoba;   Hoffmann-La Roche
    Not yet recruiting - verified November 2009

  • Concentrations of Maraviroc in the Semen of HIV-Infected Men

    Condition:   Maraviroc Concentrations in Semen
    Intervention:   Other: Measuring semen samples
    Sponsor:   Canadian Immunodeficiency Research Collaborative
    Recruiting - verified November 2009

  • RCT for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children

    Condition:   Asthma
    Interventions:   Drug: Azithromycin;   Drug: Placebo
    Sponsor:   Alberta Children's Hospital
    Not yet recruiting - verified November 2009

  • Safety of Toleromune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis

    Condition:   Allergy
    Interventions:   Biological: Toleromune HDM;   Biological: Placebo
    Sponsors:   Circassia Limited;   Adiga Life Sciences
    Not yet recruiting - verified November 2009

  • Assessing Patient Care Through Routine Use of Patient-Reported Outcomes

    Condition:   Falls
    Intervention:  
    Sponsor:   University of British Columbia
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Study of Cervix and Inflammation in Preterm Birth Prediction

    Condition:   Preterm Birth
    Interventions:   Procedure: Transvaginal ultrasound;   Procedure: Vaginal secretion sampling
    Sponsor:   Universitaire de Sherbrooke
    Recruiting - verified November 2009

  • Use of Wii Fit (TM) to Increase Compliance With Home Exercises in Treating Patellofemoral Syndrome

    Conditions:   Patellofemoral Syndrome;   Patellofemoral Pain Syndrome;   Anterior Knee Pain Syndrome
    Interventions:   Other: Wii Fit (TM) Interactive Video Game;   Other: Traditional Home Exercise Program
    Sponsor:   University of Manitoba
    Recruiting - verified November 2009

  • Comparison of LMA-Fastrach and I-gel for Blind Tracheal Intubation.

    Condition:   Patients Undergoing Elective General Anesthesia.
    Interventions:   Procedure: Tracheal intubation;   Procedure: Tracheal intubation
    Sponsor:   Centre hospitalier de l'Université de Montréal (CHUM)
    Not yet recruiting - verified November 2009

  • Flaxseed Compared With Placebo in Patients With Hypercholesterolemia

    Condition:   Familial or Severe Hypercholesterolemia
    Interventions:   Dietary Supplement: flaxseed;   Dietary Supplement: whole wheat flour
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified November 2009

  • Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator (tPA)

    Condition:   Ischemic Stroke
    Intervention:   Device: NeuroFlo catheter
    Sponsor:   CoAxia
    Active, not recruiting - verified November 2009

  • Limited Compression Ultrasound by Emergency Physicians to Exclude Deep Vein Thrombosis

    Condition:   Deep Vein Thrombosis
    Intervention:  
    Sponsors:   Queen's University;   The Physicians' Services Incorporated Foundation
    Not yet recruiting - verified November 2009

  • The Ventricular Catheter Placement Study: Assessment of Efficacy and Safety of an Ultrasound Guided Shunt Insertion Technique

    Condition:   Pediatric Hydrocephalus
    Intervention:  
    Sponsor:   University of Utah
    Recruiting - verified November 2009

  • Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)

    Conditions:   Pregnancy;   Fertility
    Intervention:  
    Sponsors:   University of Utah;   Department of Health and Human Services
    Recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Study to Determine if Monitoring of Labor Shortens the Time to Delivery

    Condition:   Pregnancy
    Intervention:   Device: BirthTrack
    Sponsor:   Barnev, Inc.
    Not yet recruiting - verified October 2009

  • Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections

    Conditions:   Pain;   Anxiety
    Interventions:   Drug: Liposomal lidocaine;   Drug: Vapocoolant spray;   Other: Rubbing adjacent to the injection site;   Other: Distraction
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified October 2009

  • Increasing Smoking Cessation Counselling in Primary Care Using a Chronic Disease Management System

    Conditions:   Delivery of Health Care;   Smoking Cessation
    Intervention:   Other: New, improved smoking cessation management module
    Sponsors:   McMaster University;   Centre for Addiction and Mental Health
    Enrolling by invitation - verified October 2009

  • Simple Warfarin Dosing Algorithm Study

    Condition:   Warfarin Dosing
    Intervention:   Other: Algorithm
    Sponsor:   Population Health Research Institute
    Recruiting - verified November 2009

  • Promoting Evidence-Based Decision-Making in India: District Evaluation Study on Health

    Conditions:   Infectious Disease;   Cardiovascular Disease
    Intervention:   Behavioral: District health information package
    Sponsors:   St. Michael's Hospital, Toronto;   Canadian International Development Agency;   Lombard Insurance Global Poverty Action Lab;   St. John's Research Institute
    Active, not recruiting - verified October 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials